0.24 CNY
106.45 M CNY
1.57 B CNY
334.00 M
About VCANBIO CELL & GENE ENGINEERING
Sector
CEO
Yong Wang
Website
Headquarters
Tianjin
Founded
1993
ISIN
CNE000000545
FIGI
BBG000BFZ7G2
Vcanbio Cell & Gene Engineering Corp., Ltd. engages in the development of life sciences technology. Its business activities include stem cell genetic engineering, venture capital, investment banking, and investment consulting. It also engages in the import and export of goods and technology. The company was founded on May 4, 1993 and is headquartered in Tianjin, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600645 is 19.92 CNY — it has decreased by −2.70% in the past 24 hours. Watch VCANBIO CELL & GENE ENGINEERING stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange VCANBIO CELL & GENE ENGINEERING stocks are traded under the ticker 600645.
600645 stock has fallen by −0.85% compared to the previous week, the month change is a 1.07% rise, over the last year VCANBIO CELL & GENE ENGINEERING has showed a 3.80% increase.
600645 reached its all-time high on Apr 24, 2015 with the price of 79.58 CNY, and its all-time low was 1.24 CNY and was reached on Jul 18, 2005. View more price dynamics on 600645 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600645 stock is 1.93% volatile and has beta coefficient of 1.21. Track VCANBIO CELL & GENE ENGINEERING stock price on the chart and check out the list of the most volatile stocks — is VCANBIO CELL & GENE ENGINEERING there?
Today VCANBIO CELL & GENE ENGINEERING has the market capitalization of 9.02 B, it has decreased by −7.86% over the last week.
Yes, you can track VCANBIO CELL & GENE ENGINEERING financials in yearly and quarterly reports right on TradingView.
600645 net income for the last quarter is 48.33 M CNY, while the quarter before that showed 45.04 M CNY of net income which accounts for 7.31% change. Track more VCANBIO CELL & GENE ENGINEERING financial stats to get the full picture.
No, 600645 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 2.21 K employees. See our rating of the largest employees — is VCANBIO CELL & GENE ENGINEERING on this list?
Like other stocks, 600645 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VCANBIO CELL & GENE ENGINEERING stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VCANBIO CELL & GENE ENGINEERING technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VCANBIO CELL & GENE ENGINEERING stock shows the buy signal. See more of VCANBIO CELL & GENE ENGINEERING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.